Wikidata entity: Q190016
C₂₆H₄₁NO₃₄S₄ (P274)

| P373 | Commons category | String | Heparins | ??? |
| P1343 | described by source | ... | Q124737633 (Armenian Soviet Encyclopedia, vol. 6) | Armenian Soviet Encyclopedia, vol. 6 |
| P527 | has part(s) | ... | Q556 (hydrogen) | hydrogen |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q682 (sulfur) | sulfur |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P31 | instance of | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q35456 (essential medicine) | essential medicine |
| P31 | instance of | ... | Q17339814 (group or class of chemical substances) | group or class of chemical substances |
| P2175 | medical condition treated | ... | Q220570 (pulmonary embolism) | pulmonary embolism |
| P361 | part of | ... | Q14864816 (cellular response to heparin) | cellular response to heparin |
| P361 | part of | ... | Q21113371 (response to heparin) | response to heparin |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P636 | route of administration | ... | Q1369403 (intravenous injection) | intravenous injection |
| P636 | route of administration | ... | Q2035485 (subcutaneous injection) | subcutaneous injection |
| P769 | significant drug interaction | ... | Q18216 (aspirin) | aspirin |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q277785 (perindopril) | perindopril |
| P769 | significant drug interaction | ... | Q307088 (abciximab) | abciximab |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q410237 (clopidogrel) | clopidogrel |
| P769 | significant drug interaction | ... | Q412050 (prostacyclin) | prostacyclin |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q416485 (Streptokinase) | Streptokinase |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q420262 (rivaroxaban) | rivaroxaban |
| P769 | significant drug interaction | ... | Q414462 (apixaban) | apixaban |
| P769 | significant drug interaction | ... | Q415366 (tirofiban) | tirofiban |
| P769 | significant drug interaction | ... | Q416232 (prasugrel) | prasugrel |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q420542 (ticagrelor) | ticagrelor |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1644947 (tenecteplase) | tenecteplase |
| P769 | significant drug interaction | ... | Q1851701 (dalteparin) | dalteparin |
| P769 | significant drug interaction | ... | Q2295855 (eptifibatide) | eptifibatide |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q3655338 (cangrelor) | cangrelor |
| P769 | significant drug interaction | ... | Q20817139 (iloprost) | iloprost |
| P769 | significant drug interaction | ... | Q45769835 (alteplase) | alteplase |
| P769 | significant drug interaction | ... | Q105969996 (enoxaparin) | enoxaparin |
| P769 | significant drug interaction | ... | Q110969665 (urokinase) | urokinase |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P279 | subclass of | ... | Q215118 (anticoagulant) | anticoagulant |
| P279 | subclass of | ... | Q40211011 (heparins) | heparins |
| P910 | topic's main category | ... | Q7210771 (Category:Heparins) | Category:Heparins |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | heparin sodium | ??? |
| P267 | ATC code | B01AB01 |
| P267 | ATC code | C05BA03 |
| P267 | ATC code | S01XA14 |
| P268 | Bibliothèque nationale de France ID | 11965281p |
| P508 | BNCF Thesaurus ID | 2979 |
| P5019 | Brockhaus Enzyklopädie online ID | heparin |
| P231 | CAS Registry Number | 9041-08-1 |
| P231 | CAS Registry Number | 9005-49-6 |
| P683 | ChEBI ID | 28304 |
| P592 | ChEMBL ID | CHEMBL1909300 |
| P592 | ChEMBL ID | CHEMBL526514 |
| P661 | ChemSpider ID | 17216115 |
| P3073 | CosIng number | 34248 |
| P3073 | CosIng number | 79492 |
| P1036 | Dewey Decimal Classification | 615.718 |
| P715 | DrugBank ID | DB01109 |
| P3117 | DSSTox substance ID | DTXSID301010914 |
| P3117 | DSSTox substance ID | DTXSID20872761 |
| P232 | EC number | 232-681-7 |
| P2566 | ECHA Substance Infocard ID | 100.029.698 |
| P4746 | Elhuyar ZTH ID | 025106 |
| P1417 | Encyclopædia Britannica Online ID | science/heparin |
| P1402 | Foundational Model of Anatomy ID | 82839 |
| P646 | Freebase ID | /m/01jjpv |
| P12385 | Gran Enciclopèdia Catalana ID | heparina |
| P1296 | Gran Enciclopèdia Catalana ID (former scheme) | 0113850 |
| P2924 | Great Russian Encyclopedia Online ID (old version) | 2353452 |
| P595 | Guide to Pharmacology Ligand ID | 4214 |
| P2057 | Human Metabolome Database ID | HMDB0001394 |
| P4168 | IEDB Epitope ID | 131188 |
| P3827 | JSTOR topic ID (archived) | heparin |
| P665 | KEGG ID | C00374 |
| P8313 | Lex ID | heparin |
| P244 | Library of Congress authority ID | sh85060283 |
| P10245 | MedlinePlus drug identifier | a682826 |
| P486 | MeSH descriptor ID | D006493 |
| P672 | MeSH tree code | D09.698.373.400 |
| P6366 | Microsoft Academic ID (discontinued) | 2777557582 |
| P2004 | NALT ID | 10265 |
| P8189 | National Library of Israel J9U ID | 987007555639605171 |
| P1368 | National Library of Latvia ID | 000305466 |
| P349 | NDL Authority ID | 00563122 |
| P691 | NL CR AUT ID | ph1144691 |
| P10283 | OpenAlex ID | C2777557582 |
| P10283 | OpenAlex ID | C2911040393 |
| P4235 | PatientsLikeMe treatment ID | heparin |
| P3417 | Quora topic ID | Heparin |
| P3345 | RxNorm CUI | 5224 |
| P5076 | Römpp online ID | RD-08-00886 |
| P11089 | UniChem compound ID | 441992 |
| P652 | UNII | T2410KM04A |
| P11143 | WikiProjectMed ID | Heparin |
| P3471 | WikiSkripta article ID | 7441 |
| P8814 | WordNet 3.1 Synset ID | 03520118-n |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 392 |
| P13591 | Yale LUX ID | concept/e6c955ec-1177-4a4c-afe9-1a869812adda |
Why not click here or view trends?
log id: 3736830